Improvement of Lipoprotein Lipid Composition in Type II Diabetic Patients With Concomitant Hyperlipoproteinemia by Acipimox Treatment: Results of a multicenter trial

D Koev, S Zlateva, Mato Sušić, D Babić, Velimir Profozić, Z Škrabalo, H Langrová, A L Cvrkalová, E Rajecová, I Klimeś

Diabetes Care · 1993 · 12 citations · 0 references

Abstract

Acipimox seems to be a useful agent for treatment of diabetic dyslipidemia and does not deteriorate glycemic control.